Press release
November 5, 2026
Biohaven Drives New Research in Graves' Disease: Phase 3 Pivotal Trial with BHV-1300 Underway and Three Scientific Posters at the 2026 American Thyroid Association Annual (ATA) Meeting
Biohaven Ltd. (BHVN)
We couldn't retrieve the full text for this release. Read it on the company's site.